Arthritis News and Research

Latest Arthritis News and Research

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Doling out pain pills post-surgery: An ingrown toenail not the same as a bypass

What's the right painkiller prescription to send home with a patient after gallbladder surgery or a cesarean section?

22 Jun 2018

Study provides clues to how cancer cells develop resistance to chemotherapies

About half of all drugs, ranging from morphine to penicillin, come from compounds that are from - or have been derived from - nature. This includes many cancer drugs, which are toxic enough to kill cancer cells.

22 Jun 2018

Scientists identify gene that triggers senescence

Scientists seeking to unlock the secrets of cellular aging have identified a gene that triggers senescence, a phenomenon in which cells stop dividing.

22 Jun 2018

Review: Stem cells appear to help fight obesity in animal models

Obesity is an increasing global health problem associated with several comorbidities and a high risk of mortality.

21 Jun 2018

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis every year in the United States, affecting 2.2% of the population.

20 Jun 2018

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix, as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial.

19 Jun 2018

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Chemists invent new method for remote chiral induction

Chemists at Scripps Research have addressed one of the most formidable challenges in synthetic chemistry by inventing a method for "enantioselective remote meta-CH activation," which enables the making of chiral molecules that were previously difficult or impossible to synthesize.

19 Jun 2018

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Research from the Department of Inflammation Biology, School of Immunology & Microbial Sciences has shown there is an increased risk of disease flare in Rheumatoid Arthritis patients who suffer from depression.

19 Jun 2018

Researchers use droplet-sized 'miniecosystems' to test therapeutic potential of molecules

Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.

19 Jun 2018

Scientists could build better drugs by learning from bacteria-derived molecules

Bacteria found in soil may harbor a potential game-changer for drug design. A new study by Scripps Research, published today in Nature Communications, suggests scientists could build better drugs by learning from bacteria-derived molecules called thiocarboxylic acids.

19 Jun 2018

New study examines how the brain plays role in rheumatoid arthritis inflammation

In patients with chronic inflammatory conditions, such as rheumatoid arthritis, there has been limited understanding of how this inflammation affects the brain.

18 Jun 2018

Weight loss of 20% or greater results in better outcomes for overweight, obese adults with knee osteoarthritis

Researchers previously showed that overweight and obese individuals with knee osteoarthritis can reduce pain by 50% and significantly improve function and mobility with a 10% or more weight loss over an 18-month period.

18 Jun 2018

Engineers develop algorithm to monitor joints of patients with arthritis

An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed, has been developed by a team of engineers, physicians and radiologists led by the University of Cambridge.

18 Jun 2018

New 3D imaging technique could improve arthritis treatment

A team of engineers, physicians and radiologists have developed an algorithm that could change the way that the severity of arthritis is assessed and treated.

18 Jun 2018

Studies provide insight into molecular changes prior to onset of arthritis

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) provide insight into molecular changes prior to the onset of arthritis which could inform future novel diagnostics and early therapeutic interventions.

18 Jun 2018

New study highlights predictors that prevent from achieving remission in early RA

The results of a study presented today at the Annual European Congress of Rheumatology report that obesity in women and current smoking in men were the strongest predictors of not achieving remission in early rheumatoid arthritis within a year.

18 Jun 2018

Study demonstrates increased levels of gum disease in people at risk of rheumatoid arthritis

The results of a study presented at the Annual European Congress of Rheumatology demonstrates increased levels of gum disease, and disease-causing bacteria, in individuals at risk of rheumatoid arthritis.

18 Jun 2018

Arthritis News and Research

Latest Arthritis News and Research

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Doling out pain pills post-surgery: An ingrown toenail not the same as a bypass

Study provides clues to how cancer cells develop resistance to chemotherapies

Scientists identify gene that triggers senescence

Review: Stem cells appear to help fight obesity in animal models

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Patients with mild Alzheimer's disease over age 65 continue to derive benefit from DBS-f treatment

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Chemists invent new method for remote chiral induction

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Researchers use droplet-sized 'miniecosystems' to test therapeutic potential of molecules

Scientists could build better drugs by learning from bacteria-derived molecules

New study examines how the brain plays role in rheumatoid arthritis inflammation

Weight loss of 20% or greater results in better outcomes for overweight, obese adults with knee osteoarthritis

Engineers develop algorithm to monitor joints of patients with arthritis

New 3D imaging technique could improve arthritis treatment

Studies provide insight into molecular changes prior to onset of arthritis

New study highlights predictors that prevent from achieving remission in early RA

Study demonstrates increased levels of gum disease in people at risk of rheumatoid arthritis

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Arthritis News and Research

Latest Arthritis News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in